8,192 Shares in Intuitive Surgical, Inc. $ISRG Bought by Elevatus Welath Management

Elevatus Welath Management acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the second quarter, Holdings Channel reports. The firm acquired 8,192 shares of the medical equipment provider’s stock, valued at approximately $4,452,000. Intuitive Surgical accounts for 1.5% of Elevatus Welath Management’s holdings, making the stock its 23rd largest holding.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Tobam increased its stake in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares during the period. Kilter Group LLC acquired a new stake in Intuitive Surgical during the 2nd quarter valued at approximately $27,000. TD Capital Management LLC raised its holdings in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC bought a new position in Intuitive Surgical during the 1st quarter worth approximately $30,000. Finally, Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

ISRG stock opened at $542.32 on Friday. The company’s 50-day moving average is $529.62 and its 200-day moving average is $506.00. The stock has a market capitalization of $194.41 billion, a PE ratio of 71.74, a price-to-earnings-growth ratio of 5.03 and a beta of 1.68. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.84 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. UBS Group set a $600.00 target price on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. BTIG Research boosted their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Rothschild & Co Redburn raised their target price on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Finally, Evercore ISI lifted their target price on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $608.79.

Insider Activity at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 3,500 shares of the stock in a transaction on Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the transaction, the executive vice president directly owned 5,758 shares in the company, valued at $3,310,850. This trade represents a 37.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. The trade was a 9.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 109,043 shares of company stock valued at $60,816,225 over the last three months. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.